Prelude Therapeutics Inc (PRLD) — Financial Flexibility Index
Prelude Therapeutics Inc (PRLD) has a Financial Flexibility Index of -0.53x as of September 2025. Free cash flow of $-19.11 Million (operating CF $-19.11 Million minus capex $0.00) represents -1% of total liabilities ($36.22 Million). Also explore net asset growth rate of Prelude Therapeutics Inc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Prelude Therapeutics Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Prelude Therapeutics Inc across 7 annual periods. Check Prelude Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Prelude Therapeutics Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Prelude Therapeutics Inc. For the full company profile including market capitalisation, see PRLD stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.32x | $-102.12 Million | $-102.89 Million | $44.06 Million | ▲ +9.2% |
| 2023 | -2.55x | $-103.55 Million | $-107.06 Million | $40.58 Million | ▲ +20.8% |
| 2022 | -3.22x | $-80.71 Million | $-83.73 Million | $25.06 Million | ▲ +23.9% |
| 2021 | -4.23x | $-81.21 Million | $-83.53 Million | $19.20 Million | ▼ -5.9% |
| 2020 | -3.99x | $-45.56 Million | $-46.18 Million | $11.41 Million | ▼ -1044.0% |
| 2019 | -0.35x | $-24.89 Million | $-25.66 Million | $71.28 Million | ▼ -9.9% |
| 2018 | -0.32x | $-12.43 Million | $-12.95 Million | $39.10 Million | — |